Coeptis Therapeutics Advances with Groundbreaking Stem Cell Therapy in Phase 2 Program
![Coeptis Therapeutics](https://nationalstemcelltherapy.com/wp-content/uploads/2023/10/Coeptis_Therapeutics_Logo.jpg)
In a significant stride towards revolutionizing the treatment of viral infections, Coeptis Therapeutics, Inc., a name synonymous with innovation in the biopharmaceutical realm, has announced its plans to embark on a Phase 2 program. This program is centered around its proprietary, first-in-class allogeneic NK cell therapy, showcasing a pivotal moment in the pursuit of advanced […]